Downregulation of ARFGEF1 and CAMK2B by promoter hypermethylation in breast cancer cells

BMB Reports

Volumn 44, Issue 8, 2011, Pages 523-528

  Kim, Ju Hee ^a   Kim, Tae Woo ^a   Kim, Sun Jung ^a  

^a Dongguk University   (South Korea)

Author keywords

ARFGEF1; Breast cancer; CAMK2B; Epigenetics; Methylation

Indexed keywords

ARFGEF1 PROTEIN, HUMAN; AZACITIDINE; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CAMK2B PROTEIN, HUMAN; GUANINE NUCLEOTIDE EXCHANGE FACTOR;

ARTICLE; BIOLOGY; BREAST TUMOR; DNA METHYLATION; DOWN REGULATION; DRUG EFFECT; ENZYMOLOGY; FEMALE; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; HUMAN; METABOLISM; POLYMERASE CHAIN REACTION; PROMOTER REGION; TUMOR CELL LINE;

AZACITIDINE; BREAST NEOPLASMS; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; CELL LINE, TUMOR; COMPUTATIONAL BIOLOGY; DNA METHYLATION; DOWN-REGULATION; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HUMANS; POLYMERASE CHAIN REACTION; PROMOTER REGIONS, GENETIC;

EID: 80052903906     PISSN: 19766696     EISSN: 1976670X     Source Type: Journal    
DOI: 10.5483/BMBRep.2011.44.8.523     Document Type: Article

References (20)

1. Kulis, M. and Esteller, M. (2010) DNA methylation and cancer. Adv. Genet 70, 27-56.
2. Dworkin, A. M., Huang, T. H. and Toland, A. E. (2009) Epigenetic alterations in the breast: Implications for breast cancer detection, prognosis and treatment. Semin. Cancer Biol. 19, 165-171.
3. Ai, L., Kim, W. J., Kim, T. Y., Fields, C. R., Massoll, N. A., Robertson, K. D. and Brown, K. D. (2006) Epigenetic silencing of the tumor suppressor cystatin M occurs during breast cancer progression. Cancer Res. 66, 7899-7909.
4. Nabilsi, N. H., Broaddus, R. R. and Loose, D. S. (2009) DNA methylation inhibits p53-mediated survivin repression. Oncogene 28, 2046-2050.
5. Singh, P., Yang, M., Dai, H., Yu, D., Huang, Q., Tan, W., Kernstine, K., Lin, D. and Shen, B. (2008) Overexpression and hypomethylation of flap endonuclease 1 gene in breast and other cancers. Mol. Cancer Res. 6, 1710-1717.
6. Ito, Y., Koessler, T., Ibrahim, A., Rai, S., Vowler, S., Abu-Amero, S., Silva, A., Maia, A., Huddleston, J., Uribe-Lewis, S., Woodfine, K., Jagodic, M., Nativio, R., Dunning, A., Moore, G., Klenova, E., Bingham, S., Pharoah, P., Brenton, J., Beck, S., Sandhu, M. and Murrell, A. (2008) Somatically acquired hypomethylation of IGF2 in breast and colorectal cancer. Hum. Mol. Genet. 17, 2633-2643.
7. Tommasi, S., Karm, D. L., Wu, X., Yen, Y. and Pfeifer, G. P. (2009) Methylation of homeobox genes is a frequent and early epigenetic event in breast cancer. Breast Cancer Res. 11, R14.
8. Van der Auwera, I., Yu, W., Suo, L., Van Neste, L., van Dam, P., Van Marck, E. A., Pauwels, P., Vermeulen, P. B., Dirix, L. Y. and Van Laere, S. J. (2010) Array-based DNA methylation profiling for breast cancer subtype discrimination. PLoS One 5, e12616.
9. Zeller, C., Hinzmann, B., Seitz, S., Prokoph, H., Burkhard-Goettges, E., Fischer, J., Jandrig, B., Schwarz, L. E., Rosenthal, A. and Scherneck, S. (2003) SASH1: a candidate tumor suppressor gene on chromosome 6q24.3 is downregulated in breast cancer. Oncogene 22, 2972-2983.
10. Hesson, L., Dallol, A., Minna, J. D., Maher, E. R. and Latif, F. (2003) NORE1A, a homologue of RASSF1A tumour suppressor gene is inactivated in human cancers. Oncogene 22, 947-954.
11. Thirlwell, C., Eymard, M., Feber, A., Teschendorff, A., Pearce, K., Lechner, M., Widschwendter, M. and Beck, S. (2010) Genome-wide DNA methylation analysis of archival formalin-fixed paraffin-embedded tissue using the Illumina Infinium HumanMethylation27 BeadChip. Methods 52, 248-254.
12. Novak, G., Seeman, P. and Tallerico, T. (2006) Increased expression of calcium/calmodulin-dependent protein kinase IIbeta in frontal cortex in schizophrenia and depression. Synapse 59, 61-68.
13. Pacheco-Rodriguez, G., Moss, J. and Vaughan, M. (2002) BIG1 and BIG2: brefeldin A-inhibited guanine nucleotideexchange proteins for ADP-ribosylation factors. Methods Enzymol. 345, 397-404.
14. Teschendorff, A. E., Menon, U., Gentry-Maharaj, A., Ramus, S. J., Gayther, S. A., Apostolidou, S., Jones, A., Lechner, M., Beck, S., Jacobs, I. J. and Widschwendter, M. (2009) An epigenetic signature in peripheral blood predicts active ovarian cancer. PLoS One 4, e8274.
15. Padilla, P. I., Uhart, M., Pacheco-Rodriguez, G., Peculis, B. A., Moss, J. and Vaughan, M. (2008) Association of guanine nucleotide-exchange protein BIG1 in HepG2 cell nuclei with nucleolin, U3 snoRNA, and fibrillarin. Proc. Natl. Acad. Sci. U. S. A. 105, 3357-3361.
16. Pfeffer, S. R. (1992) GTP-binding proteins in intracellular transport. Trends Cell Biol. 2, 41-46.
17. Gaertner, T. R., Kolodziej, S. J., Wang, D., Kobayashi, R., Koomen, J. M., Stoops, J. K. and Waxham, M. N. (2004) Comparative analyses of the three-dimensional structures and enzymatic properties of alpha, beta, gamma and delta isoforms of Ca2+-calmodulin-dependent protein kinase II. J. Biol. Chem. 279, 12484-12494.
18. Takeuchi, Y., Nomura, K. and Fukunaga, K. (2004) Differential subcellular distribution of Ca2+/calmodulin-dependent protein kinase II isoforms in the striatum and NG108-15 cells. J. Neurosci. Res. 75, 480-490.
19. Luedi, P. P., Dietrich, F. S., Weidman, J. R., Bosko, J. M., Jirtle, R. L. and Hartemink, A. J. (2007) Computational and experimental identification of novel human imprinted genes. Genome Res. 17, 1723-1730.
20. Lu, L., Katsaros, D., de la Longrais, I. A., Sochirca, O. and Yu, H. (2007) Hypermethylation of let-7a-3 in epithelial ovarian cancer is associated with low insulin-like growth factor-II expression and favorable prognosis. Cancer Res. 67, 10117-10122.